ALR Technologies SG (ALRTF) EBITDA Margin (2022)
ALR Technologies SG (ALRTF) posted EBITDA Margin of 94758.98% for Q2 2022.
ALR Technologies SG (ALRTF) EBITDA Margin (2022) Analysis & Trends
ALR Technologies SG's EBITDA Margin history runs 1 years deep, the most recent figure standing at 94758.98% for Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 10.04% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 21.42% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 6.17% |
| 10 | ALR Technologies SG | 61.20 Mn | 61.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -94,758.98% |